Zobrazeno 1 - 10 of 45 pro vyhledávání: '"Vercasson, M"'
1
Commercialanti-CD19 CART cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Autor: Sesques, P, Ferrant, E, Safar, V, Wallet, F, Tordo, J, Dhomps, A, Karlin, L, Brisou, G, Vercasson, M, Hospital-Gustem, C, Schwiertz, V, Ranchon, F, Rioufol, C, Choquet, M, Sujobert, P, Ghergus, D, Bouafia, F, Golfier, C, Lequeu, H, Lazareth, A, Novelli, S, Devic, P, Glehen, AT, Viel, S, Venet, F, Mialou, V, Hequet, O, Chauchet, A, Arkam, Y, Nicolas-Virelizier, E, Peyrade, F, Cavalieri, D, Ader, F, Ghesquieres, H, Salles, G, Bachy, E
Publikováno v: AMERICAN JOURNAL OF HEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Two autologous anti-CD19 chimeric antigen receptors (CAR) T cells (axicabtagene ciloleucel [axi-cel] and tisagenlecleucel [tisa-cel]) are commercially approved in Europe for relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). We performe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::490e3c3ba55ee9ebf4acbcde999f37a5
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13578
Zobrazit plný text záznamu
2
Akademický článek
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Autor: Sesques P, Tordo J; Departments of Nuclear Medicine., Ferrant E; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Safar V; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Wallet F; Critical Care., Dhomps A, Brisou G, Bouafia F; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Karlin L; Claude Bernard Lyon 1 University, Lyon., Ghergus D; Claude Bernard Lyon 1 University, Lyon., Golfier C, Lequeu H; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Lazareth A; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Vercasson M; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Hospital-Gustem C; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Schwiertz V; Pharmacy., Choquet M; From the Department of Haematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite., Sujobert P, Novelli S; INSERM U1052 and CNRS UMR5286, Lyon Cancer Research Center, Lyon., Mialou V; Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes., Hequet O; Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes., Carras S; Department of Haematology, Grenoble University Hospital, Grenoble., Fouillet L; Department of Haematology, Institut de Cancérologie Lucien Neuwirth, Saint-Etienne., Lebras L; Department of Haematology, Centre Léon Bérard, Lyon., Guillermin Y; Department of Haematology, Centre Léon Bérard, Lyon., Leyronnas C; Department of Haematology, Groupe Hospitalier Mutualiste, Institut Daniel Hollard, Grenoble., Cavalieri D; Department of Haematology, Clermont Ferrand University Hospital, Clermont Ferrand, France., Janier M; Departments of Nuclear Medicine., Ghesquières H, Salles G, Bachy E
Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2021 Aug 01; Vol. 46 (8), pp. 627-634.
Zobrazit plný text záznamu
3
Akademický článek
[The care process of patient receiving CAR T-cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Autor: Beauvais D; CHRU de Lille, service des maladies du sang, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. Electronic address: david_beauvais@hotmail.com., Andrianne C; CHU de Liège, service d'hématologie, avenue de l'hôpital B35, 4000 Liège, Belgique., Aubrun C; CHU d'Ambroise-Paré, service onco-hémato, 2, boulevard Kennedy, 7000 Mons, Belgique., Berquier M; AP-HP, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France., Bole S; CHU de Besançon, soins intensifs d'hématologie, boulevard Fleming, 25000 Besançon, France., Caulier A; CHU d'Amiens, hématologie clinique et thérapie cellulaire, rond-point Professeur Cabrol, 80000 Amiens, France., Courbon C; Institut cancérologie Lucien-Neuwirth (ICLN), service hématologie, 108, bis avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France., Delorme J; CHU de Montpellier, unité de soins protégés pédiatrique, 371, avenue du Doyen Gaston-Giraud, 34090 Montpellier, France., Fournier I; CHU d'Amiens, hématologie clinique et thérapie cellulaire, rond-point Professeur Cabrol, 80000 Amiens, France., François G; CHU de Nantes Hôtel Dieu, service d'hématologie, 1, place Alexis-Ricordeau, 44000 Nantes, France., Jaivenois MF; Institut Jules-Bordet, ULB, service d'hématologie, 1, rue Héger-Bordet, 1000 Bruxelles, Belgique., Le Bars L; CHU de Rennes, hématologie clinique adulte Pontchaillou, rue Henri-Le-Guilloux, 35033 Rennes, France., Mussot I; CHU de Besançon, soins intensifs d'hématologie, boulevard Fleming, 25000 Besançon, France., Vercasson M; CHU de Lyon, HCL Hôpital Lyon Sud, service d'hématologie, 165, chemin du Grand Revoyet, 69310 Pierre-Bénite, France., Wallart Brejaud A; CHRU de Lille, service des maladies du sang, 2, avenue Oscar-Lambret, 59037 Lille cedex, France., Yakoub-Agha I; CHU de Lille, université de Lille, LIRIC, Inserm U995, 59000 Lille, France., Lacroix D; CHU de Montpellier, service hématologie, 80, avenue Augustin-Fliche, 34295 Montpellier, France.
Publikováno v: Bulletin du cancer [Bull Cancer] 2020 Dec; Vol. 107 (12S), pp. S170-S177. Date of Electronic Publication: 2020 Sep 02.
Zobrazit plný text záznamu
4
Akademický článek
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Autor: Sesques P; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France., Ferrant E; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Safar V; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Wallet F; Department of Critical Care, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Tordo J; Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Dhomps A; Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Karlin L; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Brisou G; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France., Vercasson M; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Hospital-Gustem C; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Schwiertz V; Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Ranchon F; Claude Bernard Lyon 1 University, Lyon, France.; Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Rioufol C; Claude Bernard Lyon 1 University, Lyon, France.; Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Choquet M; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Sujobert P; Claude Bernard Lyon 1 University, Lyon, France.; Department of Hematology Laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Ghergus D; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Bouafia F; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Golfier C; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France., Lequeu H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Lazareth A; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Novelli S; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Devic P; Department of Neurology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Traverse Glehen A; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.; Department of Pathology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Viel S; Claude Bernard Lyon 1 University, Lyon, France.; Department of Biological Immunology, Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, France.; International Center for Research in Infectious Diseases, INSERM U1111 and CNRS UMR5308, Lyon, France., Venet F; Claude Bernard Lyon 1 University, Lyon, France.; Department of Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France., Mialou V; Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes, Decines-Charpieu, France., Hequet O; Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes, Decines-Charpieu, France., Chauchet A; Department of Hematology, Besançon University Hospital, Besançon, France., Arkam Y; Department of Hematology, Hopital Emile Muller, Mulhouse, France., Nicolas-Virelizier E; Department of Hematology, Centre Léon Bérard, Lyon, France., Peyrade F; Department of Hematology, Centre Antoine Lacassagne, Nice, France., Cavalieri D; Department of Hematology, Clermont Ferrand University Hospital, Clermont Ferrand, France., Ader F; Department of Infectious Disease, Hospices Civils de Lyon, Croix Rousse Hospital, Lyon, France., Ghesquières H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Salles G; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Bachy E; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.
Publikováno v: American journal of hematology [Am J Hematol] 2020 Nov; Vol. 95 (11), pp. 1324-1333. Date of Electronic Publication: 2020 Aug 25.
Zobrazit plný text záznamu
6
Akademický článek
A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers.
Autor: Olifirenko, Valentina1 (AUTHOR) valentina.olifirenko@nu.edu.kz, Barlev, Nikolai A.1 (AUTHOR) nikolai.barlev@nu.edu.kz
Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6595. 13p.
Zobrazit plný text záznamu
7
Akademický článek
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors.
Autor: Chen, Tong1 (AUTHOR), Wang, Mingzhao1 (AUTHOR), Chen, Yanchao1 (AUTHOR), Liu, Yutao1 (AUTHOR) liuyutao@cicams.ac.cn
Publikováno v: Cancer Cell International. 4/15/2024, Vol. 24 Issue 1, p1-24. 24p.
Zobrazit plný text záznamu
8
Akademický článek
[National care logbook for patients undergoing autologous hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Autor: Porcheron S; CLCC Henri-Becquerel, unité de soins intensifs, hématologie, 1, rue d'Amiens, 76038 Rouen cedex, France., Balcaen S; CHRU de Lille, service des maladies du sang, 2, avenue Oscar-Lambret, 59037 Lille cedex, France., Cardinael N; CLCC Henri-Becquerel, unité de soins intensifs, hématologie, 1, rue d'Amiens, 76038 Rouen cedex, France., Courbon C; Institut de cancérologie Lucien-Neuwirth, hématologie, avenue Albert-Raymond, 42270 St-Prie-en-Jarez, France., Dendoncker C; CHRU de Lille, service de nutrition, 2, avenue Oscar-Lambret, 59037 Lille cedex, France., Faivre-Lescat H; Hôpital Saint-Louis, médecine interne maladies auto-immunes et pathologies vasculaires, 1, avenue Claude-Vellefaux, 75010 Paris, France., François G; CHU de Nantes, Hôtel-Dieu, coordination, hématologie, 1, place Alexis-Ricordeau, 44093 Nantes cedex, France., Gilis L; CLCC Léon-Bérard, onco-hématologie, 28, rue Laënnec, 69373 Lyon cedex, France., Guiraud M; CHU de Montpellier, hématologie pédiatrique, avenue du Doyen-Gaston-Giraud, 34085 Montpellier, France., Schmitt S; CHU de Strasbourg, hôpital de Hautepierre, hématologie, 1, avenue Molière, 67200 Strasbourg, France., Vercasson M; CHU Lyon-Sud, hématologie greffe de CSH, 165, chemin du Grand-Revoyet, 69495 Lyon cedex, France., Adam C; CHU de Toulouse, hématologie greffe, 170, avenue de Casselardit, 31059 Toulouse, France., Yakoub-Agha I; CHRU de Lille, maladies du sang, 59037 Lille, France. Electronic address: Ibrahim.YAKOUBAGHA@CHRU-LILLE.FR.
Publikováno v: Bulletin du cancer [Bull Cancer] 2017 Dec; Vol. 104 (12S), pp. S142-S144. Date of Electronic Publication: 2017 Nov 08.
Zobrazit plný text záznamu
9
Akademický článek
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma.
Autor: Seipel, Katja1,2 (AUTHOR) dilara.akhoundovasanoyan@insel.ch, Frey, Michèle2 (AUTHOR), Nilius, Henning3 (AUTHOR) henning.nilius@insel.ch, Akhoundova, Dilara1,2 (AUTHOR), Banz, Yara4 (AUTHOR) yara.banz@unibe.ch, Bacher, Ulrike5 (AUTHOR) veraulrike.bacher@insel.ch, Pabst, Thomas2 (AUTHOR) katja.seipel@unibe.ch
Publikováno v: Current Oncology. Dec2023, Vol. 30 Issue 12, p10463-10476. 14p.
Zobrazit plný text záznamu
10
Periodical
COLLATIONNEMENT DES INFORMATIONS CONCERNANT L'EFFET D'ÉCHELLE SUR LES RENDEMENTS ET LES DÉBITS DANS LES TURBINES PELTON
Autor: VERCASSON, M.
Publikováno v: La Houille Blanche; August 1963, Vol. 1963 Issue: 5 p547-560, 14p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje